Skip to main content

Degenerative Cervical Myelopathy Patients Often Have Severe Residual Paresthesia

Medically reviewed by Carmen Pope, BPharm. Last updated on March 11, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, March 11, 2024 -- Just under half of patients (45 percent) with degenerative cervical myelopathy (DCM) show severe residual paresthesia one year after surgery, according to a study published online in the March 15 issue of Spine.

Koji Tamai, M.D., from Osaka Metropolitan University in Japan, and colleagues examined the incidence of residual paresthesias after surgery for DCM and analyzed the impact of these symptoms on clinical outcomes and patient satisfaction. The analysis included data from 187 patients who underwent laminoplasty for DCM.

The researchers found that 86 of 187 patients had severe residual paresthesia at one year postoperatively. There was a significant association between preoperative patient-oriented pain scale scores and postoperative residual paresthesia. Patients with severe postoperative residual paresthesia showed significantly smaller improvements in quality of life and myelopathy versus patients with no or mild residual paresthesia in a mixed-effect model. Furthermore, residual paresthesia was significantly associated with lower treatment satisfaction, independent of improvements in myelopathy and quality of life (adjusted odds ratio, 2.50).

"In patients who experience higher preoperative pain, multidisciplinary approaches for residual paresthesia, including medications for neuropathic pain, might lead to greater clinical satisfaction," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...

Odds of Death Lower With Surgery for Hip Fracture in Patients With Dementia

MONDAY, June 3, 2024 -- For community-dwelling patients with dementia and fracture of the femoral head and neck, the odds of death are lower for those treated surgically...

Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income

FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.